Genesis Global Group
Ingenio Diagnostics

You will now be redirected to the GD3 website

Ingenio Diagnostics is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3


Licensure & Accreditation

The Clinical Laboratory Improvement Amendments of 1988, CLIA ‘88, established quality standards for laboratory testing performed on specimens from humans, such as blood, body fluid, and tissue, to diagnose, prevent, or treat disease or assessment of health. These regulations cover all aspects of testing, including general laboratory requirements, quality monitors, pre-analytics, analytic performance, post-analytics, and personnel requirements. To summarize, CLIA establishes the rules and guidelines that laboratories must follow to ensure they are providing accurate laboratory results. Federal agencies and state Departments of Health then work together to support the CLIA amendments and enforce compliance. States requiring additional clinical laboratory certification/registration include CA, MD, NY, PA, and RI.

Our clinical laboratories are routinely inspected by both their home state Department of Health and the College of American Pathologists (CAP). They participate in the proficiency testing programs administered by both CAP and the American Proficiency Institute to maintain licensing in multiple states. They are accredited by CAP, an internationally recognized program designed to advance Laboratory Services’ quality. Through the use of rigorous checklists designed to improve the overall quality practice of the management and operation of a clinical laboratory in combination with routine peer-led inspections, a laboratory can gain accreditation by meeting or exceeding CAP standards. CAP standards are recognized to be the highest standards of excellence. Our laboratories have continually maintained exemplary ratings by these agencies.

  • CAP
  • Wadsworth
  • CLIA CLIA - ID #31D0938156
  • Clinical Laboratory License NJ - Clinical Laboratory License - ID #0000875
  • Clinical Laboratory Permit NY - Clinical Laboratory Permit - PFL #746
  • Medical Laboratory Permit MD - Medical Laboratory Permit - ID #1133
  • Clinical Laboratory Permit PA - Clinical Laboratory Permit - ID #26538A
  • Clinical Laboratory Permit RI - Clinical Laboratory Permit - ID #LCO00420
  • Clinical Laboratory Permit CA - Clinical Laboratory Permit - ID #CDS00800136

Therapeutic Areas

  • Women's HealthWomen’s Health
  • DermatologyDermatology
  • MicrobiomeMicrobiome
  • GenitourinaryGenitourinary
  • Infectious DiseaseInfectious Disease
  • OncologyOncology
  • VirologyVirology
  • Immune-based DisordersImmune-based Disorders
  • Breast CancerBreast Cancer
  • GastrointestinalGastrointestinal
A multidisciplinary Clinical Laboratory